Erin Spangler
Family · Baton Rouge, LANPI 1265921589
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,698 and has fallen 77.2% since, to $616 in 2025. Among family clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 348 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$780
- Novartis$749
- UCB, Inc.$466
- Teva Pharmaceuticals USA, Inc.$316
- Amneal Pharmaceuticals LLC$271
- Amgen$262
- plus $3K from 31 others
What the payments were for
- Speaking & faculty fees$731%
- Food & beverage$5,57097%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $780 |
| Novartis | 54 | $749 |
| UCB, Inc. | 21 | $466 |
| Teva Pharmaceuticals USA, Inc. | 23 | $316 |
| Amneal Pharmaceuticals LLC | 21 | $271 |
| Amgen(2 entities) | 15 | $262 |
| Lilly USA, LLC | 10 | $252 |
| SK Life Science, Inc. | 12 | $208 |
| Sanofi | 15 | $203 |
| Biogen | 12 | $199 |
| Novocure Inc. | 3 | $186 |
| Eisai Inc. | 6 | $178 |
| AstraZeneca(2 entities) | 6 | $172 |
| TG Therapeutics, Inc. | 2 | $163 |
| Biohaven Pharmaceuticals, Inc. | 13 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $136 |
| Acorda Therapeutics, Inc | 7 | $117 |
| Grifols USA, LLC | 6 | $112 |
| Neurocrine Biosciences, Inc. | 5 | $90 |
| Lundbeck LLC | 4 | $84 |
| CSL Behring | 5 | $80 |
| Avanir Pharmaceuticals, Inc. | 5 | $79 |
| Kyowa Kirin, Inc. | 3 | $73 |
| MDD US Operations, LLC | 3 | $56 |
| Merz Pharmaceuticals, LLC | 2 | $48 |
| Genentech USA, Inc. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Johnson & Johnson | 2 | $37 |
| Upsher-smith Laboratories LLC | 2 | $25 |
| EMD Serono, Inc. | 2 | $25 |
| Radius Health, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Argenx US, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Catalyst Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| Tanabe Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,719 in reported general payments places this provider in the 90th percentile of 3,610 family providers in Louisiana.
Other family in Baton Rouge
- Elidia DewittBaton Rouge$108K
- Ghenet GhebretatiosBaton Rouge$91K
- Heather SullivanBaton Rouge$32K
- Randee KidderBaton Rouge$30K
- Dionne BellBaton Rouge$24K
- Jennifer LittleBaton Rouge$21K
- Tracy ParkerBaton Rouge$19K
- Kristen VillarBaton Rouge$18K
- Sharon JacksonBaton Rouge$15K
- Gloria MarchandBaton Rouge$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.